Fizazi, K., Jenkins, C., & Tannock, I. F. (2015). Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra. Ann Oncol.
Citação norma ChicagoFizazi, K., C. Jenkins, and I. F. Tannock. "Should Docetaxel Be Standard of Care for Patients With Metastatic Hormone-sensitive Prostate Cancer? Pro and Contra." Ann Oncol 2015.
MLA CitationFizazi, K., C. Jenkins, and I. F. Tannock. "Should Docetaxel Be Standard of Care for Patients With Metastatic Hormone-sensitive Prostate Cancer? Pro and Contra." Ann Oncol 2015.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.